SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001354488-16-006998
Filing Date
2016-04-14
Accepted
2016-04-14 16:00:46
Documents
5
Effectiveness Date
2016-04-14

Document Format Files

Seq Description Document Type Size
1 NOTICE AND ACCESS ptx_defa14a.htm DEFA14A 40187
2 phone.jpg GRAPHIC 8848
3 fax.jpg GRAPHIC 8253
4 internet.jpg GRAPHIC 8113
5 mail.jpg GRAPHIC 8542
  Complete submission text file 0001354488-16-006998.txt   66672
Mailing Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960
Business Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960 (862) 260-8457
PERNIX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001024126 (see all company filings)

IRS No.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14494 | Film No.: 161571748
SIC: 2834 Pharmaceutical Preparations